VBI Vaccines’s $71.9 Million underwritten public offering and concurrent registered direct offering of common shares

Haynes and Boone, LLP represented client VBI Vaccines Inc. in its successful underwritten public offering and concurrent registered direct offering of common shares for aggregate gross...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here